GlassScriptPhysician profile
Amit K Sharma
NPI 1730396706
$340,523.94
in general payments reported to CMS, 2019-2025
33 companies · $861 in 2025
The $861 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $141K · 2020: $36K · 2021: $29K · 2022: $70K · 2023: $38K · 2024: $25K · 2025: $861.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $52K · Travel and Lodging: $8,602 · Food and Beverage: $3,440.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $52,030.00 |
| Travel and Lodging | $8,601.87 |
| Food and Beverage | $3,439.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $308,173.50 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $22,624.99 | 2019-2025 | |
| Abbott Laboratories | $2,189.41 | 2023 | Amplatzer Amulet |
| Penumbra, INC. | $1,890.48 | 2023-2024 | Indigo System, Penumbra System |
| Boston Scientific Corporation | $1,645.18 | 2019-2025 | Accolade Sr, Avvigo Guidance System, General - Balloon Catheters |
| Astrazeneca Pharmaceuticals LP | $1,069.75 | 2019-2023 | Farxiga |
| Abiomed | $671.31 | 2019-2025 | Impella |
| Medtronic, INC. | $265.34 | 2021-2025 | Linq II |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $197.02 | 2019-2025 | Lifevest |
| Shockwave Medical, INC | $184.81 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Biosense Webster, INC. | $182.30 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $175.50 | 2019-2025 | Camzyos, Eliquis |
| Amarin Pharma, INC. | $157.73 | 2019 | |
| Baylis Medical Company INC | $149.18 | 2019 | |
| Amgen INC. | $120.71 | 2023-2025 | Repatha, Repatha |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $108.43 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $97.70 | 2022-2025 | Jardiance |
| Pfizer INC. | $83.81 | 2022-2025 | |
| Cvrx, INC. | $79.27 | 2023-2025 | Barostim Neo System |
| Vital Connect, INC | $67.41 | 2025 | Vitalpatch Rtm |
| Impulse Dynamics (USA) INC. | $65.22 | 2024 | Optimizer |
| Kerecis Limited | $61.50 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Esperion Therapeutics, INC. | $45.80 | 2024-2025 | Nexletol |
| Novo Nordisk INC | $33.83 | 2025 | Wegovy |
| Astellas Pharma US INC | $30.00 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $29.57 | 2024 | |
| Vivaquant INC, Dba Rhythm Express | $24.63 | 2024 | Rhythm Express |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $23.52 | 2023 | Arazlo, Jublia |
| Bayer Healthcare Pharmaceuticals INC. | $23.46 | 2024 | |
| Kestra Medical Technology Services, INC. | $19.45 | 2024 | Assure Wcd |
| Biotronik INC. | $14.48 | 2025 | Biomonitor |
| Mml US, INC. | $13.87 | 2022 | |
| Cardiovascular Systems INC. | $4.78 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.